ARCH VENTURE FUND IX, L.P. - BEAM THERAPEUTICS -- SCH 13G

Company

Beam Therapeutics Inc.

Filed

February 2, 2021

Accession Number

0001072613-21-000065

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →